NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/31/2022
Back to search
Official data from USPTO
REVATIS REGENERATIVE MEDICINE AND CELL THERAPY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000090553103Class
5, 10, 40, 42, 44
Filing
90553103
Registration
6742715
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
05/31/2022
Trademark type
Combined
Nice classes
5, 10, 40, 42, 44
Filing date
03/01/2021
Registration date
05/31/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/31/2022
Last transaction
05/31/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
99
Owner location
LIEGE, BE
Examiner
AGOSTO, GISELLE
Law office
L20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a blue rectangular carrier in which appears the stylized wording "REVATIS" where "REVA" appears in green and "TIS" appears in white with the letter "I" formed by three vertically aligned white dots; below this wording appears the smaller stylized white wording "REGENERATIVE MEDICINE AND CELL THERAPY".
Holders and representatives
Holders
REVATIS S.A.
Representatives
Nicholas D. Wells LEGENDS LAW GROUP, PLLC
Technical classification
Nice Classes
Class 5Class 10Class 40Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical products for regenerative medicine; orthopedic articleslubricating gel
Class 10
Medical apparatus and instruments for veterinary purposes and for use in surgery as it relates to regenerative medicine; cell culture apparatus for medical or veterinary usecell culture chambers; orthopedic articlesbone prosthesesjoint prosthesesmedical instruments for use in performing biopsies in the nature of microbiopsies
Class 40
Cell cryopreservation services
Class 42
Development of pharmaceutical products; development of cell therapy products; development of technologies for the manufacture and processing of cells for use in advanced cell therapy; Research and development of new products for others
Class 44
Veterinary services; Beauty and hygiene care services for animals; Skin care services being hygiene and beauty care; medical services
Publications
History of USPTO decisions and trademark events.
22 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/31/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/15/2022
PUBO
PUBLISHED FOR OPPOSITION
03/15/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/23/2022
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/10/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/08/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
02/08/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/08/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
02/08/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/08/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/08/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/08/2022
ALIE
ASSIGNED TO LIE
02/01/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/28/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/22/2021
GNRT
NON-FINAL ACTION E-MAILED
09/22/2021
CNRT
NON-FINAL ACTION WRITTEN
09/22/2021
DOCK
ASSIGNED TO EXAMINER
09/22/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/01/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/30/2021
NWAP
NEW APPLICATION ENTERED
03/04/2021
Continuous trademark protection
Get notified about every new filing that threatens REVATIS REGENERATIVE MEDICINE AND CELL THERAPY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.